HKSE - Delayed Quote HKD

LIVZON PHARMA (1513.HK)

26.700
+0.300
+(1.14%)
At close: 4:08:33 PM GMT+8

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 3.18B
Earnings --

Q2'24

Q3'24

Q4'24

Q1'25

0
1B
2B
3B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

20.55 Low
30.47 Average
26.700 Current
34.33 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in CNY Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1146
Avg. Estimate 3.13B2.87B12.23B12.91B
Low Estimate 3.13B2.87B12.02B12.2B
High Estimate 3.13B2.87B12.42B14.14B
Year Ago Sales 3.04B2.8B11.81B12.23B
Sales Growth (year/est) 3.13%2.69%3.57%5.56%

Earnings History

Currency in CNY 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 0.550.570.370.7
EPS Actual 0.620.540.430.71
Difference 0.07-0.030.070.01
Surprise % 12.73%-5.26%17.81%1.43%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
1513.HK --------
S&P 500 13.20%2.98%8.01%13.77%

Related Tickers